Company: AEMD
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001683168-25-006049
Chunk: 87

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Item 5
Chunk 87
---
, 2024.
     
    8-K
     
    001-37487
     
    4.1
     
    May 17, 2024

    4.6
     
    Form of Class B Warrant to Purchase Common Stock, issued on May 17, 2024.
     
    8-K
     
    001-37487
     
    4.2
     
    May 17, 2024

    4.7
     
    Form of Pre-Funded Warrant to Purchase Common Stock, issued on May 17, 2024.
     
    8-K
     
    001-37487
     
    4.3
     
    May 17, 2024

    31.1
     
    Certification
of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange
Act of 1934.

    X

    32.1^
     
    Certification
of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

    X

    101.INS
     
    Inline XBRL Instance Document with Embedded Linkbase Documents 

    X

    101.SCH
     
    Inline XBRL Taxonomy Extension Schema Document

    X

    104
     
    Cover Page Interactive Data File (formatted in XBRL, and included in exhibit 101)

    ^
    The information in Exhibit 32.1 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.

 26 

SIGNATURES

Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    AETHLON MEDICAL, INC.

    Date: August 13, 2025
    By:
    /s/ JAMES B. FRAKES

    JAMES B. FRAKES

    CHIEF EXECUTIVE OFF